MagicTime Medicine is a Yale spinout biotech startup, pioneering novel viral and non-viral gene delivery, immune modulation and vaccine approaches for the treatment of cancer and various other diseases. The technology was developed with funding from the Blavatnik Fund for Innovation at Yale.